FICCI today organised a seminar on Deciphering the WHO NUGAG guidelines on the Use of Non-Sugar Sweeteners (NSS). The seminar provided an overview of the latest scientific evidence and recommendations on NSS from the World Health Organization (WHO) and leading Indian experts. FICCI acknowledged the
Awards worth Rs.1.20 crores presented to the Awardees as a small token of our appreciation & eternal gratitude. Sitaram Jaipuria Foundation organized the prestigious Medical & Healthcare Excellence Awards 2022. This event was organized to recognize the invaluable and inspiring work of the Life Savers across
Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an oral formulation for the first time. Oral semaglutide will be a gamechanger for people with type 2 diabetes who prefer oral medications over injections. was
Dr. V. Mohan, President, Madras Diabetes Research Foundation (MDRF) & Chairman, Dr. Mohan’s Diabetes Specialities Centre, has been ranked and recognised as Tamil Nadu’s topmost scientist-cum-researcher in a list compiled and published by Stanford University, Elsevier BV and SciTech Strategies. A team from Stanford University along
Boehringer Ingelheim Supports his Call to Recognize ‘June’ as Diabetes Control Month Dr. V. Mohan, Chairman & Chief Diabetologist Dr. Mohan’s Diabetes Specialities Centre, has made an urgent plea to all diabetes management organisations, institutions and people including doctors, hospitals, clinics, NGOs, Governments, and the public
